Late lumen enlargement after drug-coated balloon angioplasty for de novo coronary artery disease

A Correction to this article is available

This article has been updated

Abstract

We aimed to identify predictors of late lumen enlargement (LLE) after drug-coated balloon (DCB) angioplasty for de novo coronary lesions. LLE, which is defined as an increase in the luminal diameter of the vessel from the immediate postprocedural measurement to follow-up measurements, is frequently observed after DCB angioplasty for de novo coronary artery disease. No predictors of LLE are known. This retrospective observational study analyzed 196 de novo coronary lesions in 182 patients who underwent both DCB angioplasty and follow-up angiography. Of the 196 lesions, 109 (56%) developed LLE during a mean follow-up period of 7.2 ± 2.5 months. As defined by American College of Cardiology (ACC)/American Heart Association (AHA) lesion types, lesions with LLE were significantly less severe than lesions without LLE (types A, B1, B2 and C 15%, 35%, 38% and 13% vs. 7%, 24%, 45% and 24%, respectively; p = 0.036), although no significant differences in clinical or other lesion background characteristics were observed between the groups. Among type C lesions, chronic total occlusion (CTO) was more frequently observed in lesions with LLE than in lesions without LLE (79% vs 43%, p = 0.036). Lesion severity predicts LLE after DCB angioplasty for de novo coronary artery disease. Among type C lesions, CTO is expected in lesions showing LLE, and preparations should therefore be made prior to DCB application. Further research is needed.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Change history

  • 17 September 2020

    An amendment to this paper has been published and can be accessed via the original article.

References

  1. 1.

    Scheller B, Fischer D, Clever YP, Kleber FX, Speck U, Bohm M, et al. Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months. Clin Res Cardiol. 2013;102:469–72.

    Article  Google Scholar 

  2. 2.

    Kleber FX, Schulz A, Waliszewski M, Hauschild T, Bohm M, Dietz U, et al. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. Clin Res Cardiol. 2015;104:217–25.

    CAS  Article  Google Scholar 

  3. 3.

    Funatsu A, Nakamura S, Inoue N, Nanto S, Nakamura M, Iwabuchi M, et al. A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease. Clin Res Cardiol. 2017;106:824–32.

    CAS  Article  Google Scholar 

  4. 4.

    Onishi T, Onishi Y, Kobayashi I, Umezawa S, Niwa A. Drug-coated balloon angioplasty for de novo small vessel disease including chronic total occlusion and bifurcation in real-world clinical practice. Cardiovasc Interv Ther. 2019;34:139–48.

    CAS  Article  Google Scholar 

  5. 5.

    Funatsu A, Kobayashi T, Mizobuchi M, Nakamura S. Clinical and angiographic outcomes of coronary dissection after paclitaxel-coated balloon angioplasty for small vessel coronary artery disease. Cardiovasc Interv Ther. 2019;34:317–24.

    Article  Google Scholar 

  6. 6.

    Kleber FX, Mathey DG, Rittger H, Scheller B, German Drug-eluting Balloon Consensus G. How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention. 2011;7(Suppl K):K125–K128128.

    Article  Google Scholar 

  7. 7.

    Cortese B, Berti S, Biondi-Zoccai G, Colombo A, Limbruno U, Bedogni F, et al. Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. Catheter Cardiovasc Interv. 2014;83:427–35.

    Article  Google Scholar 

  8. 8.

    Huber MS, Mooney JF, Madison J, Mooney MR. Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol. 1991;68:467–71.

    CAS  Article  Google Scholar 

  9. 9.

    Rissanen TT, Uskela S, Siljander A, Karkkainen JM, Mantyla P, Mustonen J, et al. Percutaneous coronary intervention of complex calcified lesions with drug-coated balloon after rotational atherectomy. J Interv Cardiol. 2017;30:139–46.

    Article  Google Scholar 

  10. 10.

    Ueno K, Morita N, Kojima Y, Takahashi H, Kawasaki M, Ito R, et al. Safety and long-term efficacy of drug-coated balloon angioplasty following rotational atherectomy for severely calcified coronary lesions compared with new generation drug-eluting stents. J Interv Cardiol. 2019;2019:9094178.

    Article  Google Scholar 

  11. 11.

    Nagai T, Mizobuchi M, Funatsu A, Kobayashi T, Nakamura S. Acute and mid-term outcomes of drug-coated balloon following rotational atherectomy. Cardiovasc Interv Ther. 2019;35:242–9.

    Article  Google Scholar 

  12. 12.

    Sato A, Kijima M, Ichimura S, Yaegashi D, Anzai F, Shimizu T, et al. Short-term outcome of percutaneous coronary intervention with directional coronary atherectomy followed by drug-coated balloon: a preliminary report. Cardiovasc Interv Ther. 2019;34:149–54.

    CAS  Article  Google Scholar 

  13. 13.

    Koln PJ, Scheller B, Liew HB, Rissanen TT, Ahmad WA, Weser R, et al. Treatment of chronic total occlusions in native coronary arteries by drug-coated balloons without stenting—a feasibility and safety study. Int J Cardiol. 2016;225:262–7.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to express our gratitude to the staff members of our department and to our radiology technicians, medical engineering staff and nurses, all of whom support our daily clinical practice.

Funding

None.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Takayuki Onishi.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 76 kb)

About this article

Verify currency and authenticity via CrossMark

Cite this article

Onishi, T., Onishi, Y., Kobayashi, I. et al. Late lumen enlargement after drug-coated balloon angioplasty for de novo coronary artery disease. Cardiovasc Interv and Ther (2020). https://doi.org/10.1007/s12928-020-00690-2

Download citation

Keywords

  • Drug-coated balloon
  • Coronary artery disease
  • Late lumen enlargement